274 related articles for article (PubMed ID: 17639499)
21. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
[TBL] [Abstract][Full Text] [Related]
22. Role for inhibitor of differentiation/deoxyribonucleic acid-binding (Id) proteins in granulosa cell differentiation.
Johnson AL; Haugen MJ; Woods DC
Endocrinology; 2008 Jun; 149(6):3187-95. PubMed ID: 18325989
[TBL] [Abstract][Full Text] [Related]
23. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo.
Gu J; Wang B; Liu Y; Zhong L; Tang Y; Guo H; Jiang T; Wang L; Li Y; Cai L
Eur J Cancer; 2014 Apr; 50(6):1184-94. PubMed ID: 24447832
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.
Patel D; Chaudhary J
Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737
[TBL] [Abstract][Full Text] [Related]
25. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
26. Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein.
Hsu JC; Dev A; Wing A; Brew CT; Bjeldanes LF; Firestone GL
Biochem Pharmacol; 2006 Dec; 72(12):1714-23. PubMed ID: 16970927
[TBL] [Abstract][Full Text] [Related]
27. The expression and roles of inhibitor of DNA binding helix-loop-helix proteins in the developing and adult mouse retina.
Du Y; Yip HK
Neuroscience; 2011 Feb; 175():367-79. PubMed ID: 21145943
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Inhibitor of differentiation (Id) proteins in human cornea.
Mohan RR; Morgan BR; Anumanthan G; Sharma A; Chaurasia SS; Rieger FG
Exp Eye Res; 2016 May; 146():145-153. PubMed ID: 26712606
[TBL] [Abstract][Full Text] [Related]
29. Human calcium/calmodulin-dependent serine protein kinase regulates the expression of p21 via the E2A transcription factor.
Sun R; Su Y; Zhao X; Qi J; Luo X; Yang Z; Yao Y; Luo X; Xia Z
Biochem J; 2009 Apr; 419(2):457-66. PubMed ID: 19125693
[TBL] [Abstract][Full Text] [Related]
30. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
31. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.
Sharma P; Chinaranagari S; Patel D; Carey J; Chaudhary J
Cancer Med; 2012 Oct; 1(2):176-86. PubMed ID: 23342267
[TBL] [Abstract][Full Text] [Related]
33. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
35. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic role of CCAAT box-binding transcription factor NF-Y on ID gene family in human embryonic carcinoma cells.
Moeinvaziri F; Shahhoseini M
IUBMB Life; 2015 Nov; 67(11):880-7. PubMed ID: 26509926
[TBL] [Abstract][Full Text] [Related]
37. Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells.
Tepper CG; Gregg JP; Shi XB; Vinall RL; Baron CA; Ryan PE; Desprez PY; Kung HJ; deVere White RW
Prostate; 2005 Dec; 65(4):375-89. PubMed ID: 16037992
[TBL] [Abstract][Full Text] [Related]
38. Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation.
Simbulan-Rosenthal CM; Trabosh V; Velarde A; Chou FP; Daher A; Tenzin F; Tokino T; Rosenthal DS
Oncogene; 2005 Aug; 24(35):5443-58. PubMed ID: 16007217
[TBL] [Abstract][Full Text] [Related]
39. Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
Ciarapica R; Annibali D; Raimondi L; Savino M; Nasi S; Rota R
Oncogene; 2009 Apr; 28(17):1881-91. PubMed ID: 19330020
[TBL] [Abstract][Full Text] [Related]
40. Iron nanoparticles significantly affect the in vitro and in vivo expression of Id genes.
Zou J; Wang X; Zhang L; Wang J
Chem Res Toxicol; 2015 Mar; 28(3):373-83. PubMed ID: 25522732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
